WATSON 3451 50 mg (Morphine sulfate extended release 50 mg)
Pill imprint WATSON 3451 50 mg has been identified as Morphine sulfate extended release 50 mg.
Morphine is used in the treatment of chronic pain; pain and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Morphine 50 mg has a high potential for abuse. The drug has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse of the drug may lead to severe psychological or physical dependence.
See also related documents.
Images for WATSON 3451 50 mg (Morphine sulfate extended release 50 mg)
- Imprint:
-
WATSON 3451
50 mg - Strength:
- 50 mg
- Color:
- Blue & White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Narcotic analgesics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 2 - High potential for abuse
- Manufacturer:
- Watson Laboratories, Inc.
More resources
Morphine sulfate extended release is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
